Successful treatment of acquired haemophilia A

被引:1
|
作者
Andrea, Kovacs [1 ]
Balazs, Tajti [1 ]
Istvan, Szoboszlay [2 ]
Zsuzsanna, Bereczky [3 ]
Peter, Ilonczai [1 ]
机构
[1] Markhot Ferenc Oktatokorhaz & Rendeloint, Belgyogyaszati Osztaly, Eger, Hungary
[2] Markhot Ferenc Oktatokorhaz & Rendeloint, Kozponti Lab, Eger, Hungary
[3] Debreceni Egyet, Altalanos Orvostud Kar, Klin Kozpont, Lab Med Int,Klin Lab Kutato Tanszek, Debrecen, Hungary
关键词
acquired haemophilia; coagulation factor; activated partial thromboplastin time; MANAGEMENT; PROPHYLAXIS; INHIBITORS; DIAGNOSIS; THERAPY;
D O I
10.1556/650.2021.32245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired haemophilia A is a rare autoimmune disorder, in which antibodies are formed against coagulation factor VIII. The effect of the inhibitor on blood clotting results in severe, life-threatening bleeding diathesis. The patient's life depends on the rapid diagnosis: besides the characteristic clinical presentation, a prolonged activated partial thromboplastin time, which is not corrigible with normal plasma, suggests the existence of the disorder. In the case of the female patient who was referred to our hospital due to severe anaemia, acquired haemophilia A was diagnosed rapidly, the day after her admission. We used activated prothrombin complex concentrate to stop the bleeding, and introduced immunosuppressive therapy. The early recognition of the disease and immediate initiation of adequate treatment resulted in the patient's full recovery. With our case presentation, we would like to draw attention to the fact that the rapid diagnosis of acquired haemophilia A depends on the determination of a simple, easily accessible coagulation parameter, the activated partial thromboplastin time and on the immediate recognition of its incorrigible prolongation.
引用
收藏
页码:1977 / 1981
页数:5
相关论文
共 50 条
  • [31] Acquired haemophilia A after alemtuzumab treatment of multiple sclerosis
    Brink, Huguette S.
    Moll, Wibe
    Sandberg, Yorick
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : 13 - 13
  • [32] Treatment of acquired haemophilia A with recombinant factor VIIa.
    Hay, CRM
    Ludlam, CA
    BLOOD, 1996, 88 (10) : 131 - 131
  • [33] Acquired haemophilia: Epidemiology, clinical presentation, diagnosis and treatment
    Eva Mingot-Castellano, Maria
    Nunez, Ramiro
    Javier Rodriguez-Martorell, Francisco
    MEDICINA CLINICA, 2017, 148 (07): : 314 - 322
  • [34] Successful perioperative prophylaxis with susoctocog alfa in a patient with acquired haemophilia A: A case study
    Buczma, Anna
    Baran, Beata
    Korwin, Magdalena
    Odnoczko, Edyta
    Windyga, Jerzy
    HAEMOPHILIA, 2022, 28 (02) : E39 - E41
  • [35] Rebound elevation of factor VIII:C levels following successful treatment for acquired haemophilia:: a risk factor for venous thrombosis?
    Grimley, CE
    Dolan, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 46 - 47
  • [36] Successful immune tolerance induction treatment of therapy-resistent acquired haemophilia with high inhibitor titer:: a case report
    Ilonczai, P.
    Schlammadinger, A.
    Olah, Zs.
    Razso, K.
    Bereczky, Zs.
    Boda, Z.
    BLOOD REVIEWS, 2007, 21 : S102 - S102
  • [37] Successful treatment of a severe inhibiting systemic haemophilia with Rituximab
    Laubenthal, L.
    Specker, Ch.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 65 - 66
  • [38] Successful treatment of canine haemophilia A with porcine factor VIII
    Lutze, G
    Kutschmann, K
    Thomae, K
    Lutze, G
    Franke, D
    PRAKTISCHE TIERARZT, 1999, 80 (08): : 664 - +
  • [39] Management of acquired haemophilia A
    Collins, P. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 714 - 714
  • [40] Acquired Haemophilia: an Update
    Schmalzing, Marc
    AKTUELLE RHEUMATOLOGIE, 2022, 47 (06) : 502 - 505